Atlas.
Sign inStart free trial
STAANASDAQ · US

STAAR SURGICAL CO

Technology · Ophthalmic Goods

TechnologyOphthalmic Goods
CEO
Warren Foust
Founded
—
IPO Date
—
HQ
Monrovia, CA, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$28.15 ▲ 19.3%
Last (1 Jul 2026) · $28
Period High · $33.34
Period Low · $16.10
52W: $16.10 – $33.34

Key Metrics

Share Price
$28.15
-1.9% today
Market Cap
$1.4B
P / E
—
EV / Revenue
5.2x
Revenue Growth
-23.7%
year-on-year
Gross Margin
+76.2%
Enterprise Value
$1.2B
52W High
$33.34
52W Low
$16.10
Avg Volume
928K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$244M total on record·2026-Q1
BlackRock, Inc.
13.4%·$125M
State Street Corp
3.7%·$34M
Goldman Sachs Group Inc
2.2%·$20M
Geode Capital Management, LLC
2.0%·$19M
Point72 Asset Management, L.P.
1.7%·$15M
Dimensional Fund Advisors LP
1.7%·$15M
Northern Trust Corp
0.8%·$7M
Invesco Ltd.
0.3%·$3M
Renaissance Technologies LLC
0.3%·$3M
Bank Of America Corp
0.1%·$1M
Price T Rowe Associates Inc
0.1%·$964
Jpmorgan Chase & Co
0.1%·$683,972
Fmr LLC
0.0%·$321,051
Free Float
73.7%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for STAAR SURGICAL CO
OverviewSTAAR SURGICAL CO share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow STAAR SURGICAL CO generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsSTAAR SURGICAL CO's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualitySTAAR SURGICAL CO executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsSTAAR SURGICAL CO's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for STAAR SURGICAL CO, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for STAAR SURGICAL CO aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersSTAAR SURGICAL CO valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for STAAR SURGICAL CO with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for STAAR SURGICAL CO — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial